Finance

Lists
STLN:NASDAQ
Starling Oncology, Inc.
$6.59
+0.17%
(+0.011) 1D
Oct 7, 10:20:28 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STLN...
Open
$6.50
High
$6.61
Low
$6.46
Mkt. cap
678.50M
Avg. vol.
1.25M
Volume
42.61K
52-wk high
$7.13
52-wk low
$4.85
EPS
-$0.31
Beta
0.37
Shares outstanding
99.98M
No. of employees
641
Open
$6.50
High
$6.61
Low
$6.46
Mkt. cap
678.50M
Avg. vol.
1.25M
Volume
42.61K
52-wk high
$7.13
52-wk low
$4.85
EPS
-$0.31
Beta
0.37
Shares outstanding
99.98M
No. of employees
641
News stories
From web sources and news partners
About Starling Oncology, Inc.
CEO-
Employees641
Founded2007
HeadquartersCerritos, California, United States
SectorHealth care provider
Websitestarlingoncology.com
Analyst ratings
Based on 3 analysts giving stock ratings to STLN in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for STLN in the last 3 months.
Highest
Current $6.59
$11.00 (+66.89%)
Average
$9.00 (+36.55%)
Lowest
$7.00 (+6.21%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Shea
Needham
Buy
Reiterated
$7.00
+6.2%
08/07/2026
Yuan Zhi
B. Riley Securities
Buy
Maintained
$11.00
+66.9%
08/07/2026
David Larsen
BTIG
Buy
Maintained
$9.00
+36.5%
07/15/2026
Ben Haynor
Lake Street
Buy
Initiated
$10.00
+51.7%
07/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
136.56M
141.96M
147.44M
161.28M
Cost of goods sold
117.64M
119.19M
124.13M
134.12M
Cost of revenue
117.64M
119.19M
124.13M
134.12M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.25M
28.04M
28.21M
29.94M
Operating expense
26.97M
29.67M
29.83M
31.78M
Total operating expenses
144.62M
148.86M
153.95M
165.90M
Operating income
-8.05M
-6.91M
-6.51M
-4.62M
Other non operating income
-6.53M
1.31M
5.96M
-3.31M
EBT including unusual items
-16.50M
-7.51M
-2.49M
-9.79M
EBT excluding unusual items
-16.50M
-7.51M
-2.49M
-9.79M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.50M
-7.51M
-2.49M
-9.79M
Net profit margin
-12.09%
-5.29%
-1.69%
-6.07%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.92M
-1.92M
-1.93M
-1.86M
Net interest expenses
-1.92M
-1.92M
-1.93M
-1.86M
Depreciation and amortization charges
1.72M
1.63M
1.62M
1.84M
EBITDA
-6.33M
-5.28M
-4.90M
-2.78M
Gain or loss from assets sale
-
-
-
28.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps